Showing results (71-80 of 87) with videos related to
Sort By:
Pageof 9
Cancer|November 1, 1982
Patterns of failure in small cell carcinoma of the lungL Y Chak, J R Daniels, B I Sikic, et al.Cancer|November 15, 1985
Gynecomastia in testicular cancer patients. Prognostic and therapeutic implicationsA Tseng, S J Horning, F S Freiha, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Superficial bladder cancer: the primacy of grade in the development of invasive diseaseF M Torti, B L Lum, D Aston, et al.Cancer Treatment Reports|July 1, 1982
AMSA--a promising new agent in refractory acute leukemiaH J Lawrence, C A Ries, R D Reynolds, et al.British Journal of Urology|September 1, 1994
Transrectal ultrasound in the evaluation of rhabdomyosarcoma involving the prostateM K Terris, E B Eigner, E M Briggs, et al.Cancer Research|September 1, 1993
Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humansM J Bargetzi, M Lantz, C G Smith, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 1, 1989
Efficient scheduling of cystoscopies in monitoring for recurrent bladder cancerD L Kent, R Shachter, H C Sox, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1983
Weekly doxorubicin in endocrine-refractory carcinoma of the prostateF M Torti, D Aston, B L Lum, et al.The Journal of Urology|December 1, 1985
The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group studyF J Meyers, J M Palmer, F S Freiha, et al.Biochemical Society Transactions|August 28, 2002
Novel cytotoxic chelators that bind iron(II) selectively over zinc(II) under aqueous aerobic conditionsR P Planalp, A M Przyborowska, G Park, et al.Pageof 9